# Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole.

> **NCT03513393** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 11 (actual)

## Conditions studied

- Hepatitis C
- Swallowing Disorder

## Interventions

- **DRUG:** velpatasvir
- **DRUG:** velpatasvir
- **DRUG:** velpatasvir

## Key facts

- **NCT ID:** NCT03513393
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-08-01
- **Primary completion:** 2018-12-01
- **Final completion:** 2018-12-01
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2020-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03513393

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03513393, "Influence of Cola on the Absorption of the HCV Agent Velpatasvir in Combination With PPI Omeprazole.". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT03513393. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*